Dr. Thanmaya Gaddam Reddy, MD

Dr. Reddy practices at Urology Clinics of North Texas in Dallas, Texas.

Dr. Reddy's NPI, 1265799332, was assigned on April 13, 2012. Dr. Reddy graduated from LSU Health Shreveport School of Medicine in 2012. Dr. Reddy's Georgia license number on file is 077899.

Dr. Reddy's primary practice is Urology Clinics of North Texas, at 9900 N Central Expy, Dallas, TX 75231 in Dallas County. The practice phone is (214) 691-1902.

Dr. Reddy's primary practice is Urology Clinics of North Texas in Dallas, Texas. Dr. Reddy is also affiliated with Medical City Dallas Hospital. The medical group on file is Urology Clinics of North Texas. Dmand AI also links Dr. Reddy to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reddy practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Reddy's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Reddy is board certified in urology by the American Board of Urology. Dmand AI has Dr. Reddy's licenses on file in 3 states: Georgia, Texas and Alabama.

Dmand AI lists bladder disease, enlarged prostate, kidney cysts, kidney stone disease, pelvic prolapse, transurethral procedures, urinary endoscopy and UTI among the conditions Dr. Reddy treats.

CMS data shows 1,309 Medicare services from Dr. Reddy across 15 procedure codes in 2024, for 224 Medicare patients. Medicare paid $47,900 for them. Every service was in an office.

CMS counts 224 Medicare patients who saw Dr. Reddy in 2024. The largest group is 75 to 84, with 98 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reddy's median patient age at 64, with 63% women.

In 2024, Dr. Reddy wrote 621 Medicare Part D claims for 181 patients. 80% of them were for generic drugs. CMS names the drug for 549 of them, across 12 drugs with 11 or more claims each, at $90,934 in total drug cost. In 2023, CMS named 173 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Reddy for performance year 2024, reported as part of a group. Dr. Reddy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reddy as offering telehealth.

Dmand AI links 5 papers to Dr. Reddy, published from 2015 to 2018. The most frequent topics are Kidney Calculi and Oxalates. Dr. Reddy's most frequent co-authors are Dean G. Assimos, Soroush Rais-Bahrami, MD and Ojas Shah, MD.

CMS Open Payments shows 75 general payments to Dr. Reddy from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Boston Scientific Corporation paid the most, $455.

Dr. Reddy graduated from LSU Health Shreveport School of Medicine in 2012.

Dr. Reddy is in network with 20 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.